» Articles » PMID: 32192483

The Prognostic Value of Routine Preoperative Blood Parameters in Muscle-invasive Bladder Cancer

Overview
Journal BMC Urol
Publisher Biomed Central
Specialty Urology
Date 2020 Mar 21
PMID 32192483
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A routine blood examination is one of the most rapid, convenient and inexpensive clinical examinations that can reflect a patient's inflammatory status and other blood conditions, and the prognostic value of routine preoperative blood parameters in MIBC patients is still unclear, so we evaluated the prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer (MIBC) following radical cystectomy (RC).

Methods: Data on 202 patients with MIBC who underwent RC at our institution were retrospectively collected between October 2007 and August 2018. The median preoperative neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and hemoglobin (HGB) values were used as cutoffs to form the low and high NLR, low and high PLR, and low and high HGB groups, respectively. The clinicopathologic characteristics of each group were compared by chi-square and t tests. Kaplan-Meier survival and multivariate Cox regression analyses were used to analyze prognosis.

Results: The median NLR, PLR and HGB values were 2.42, 112 and 125 g/L, respectively. Kaplan-Meier results showed that the low HGB group had poor progression-free survival (PFS), cancer-specific survival (CSS) and overall survival (OS). A high NLR and high PLR groups correlated only with poor OS. Multivariate Cox analyses showed that pathological T3/4 stage, positive lymph node status and low HGB were independent risk factors for PFS, CSS and OS, and age was the only independent risk factor for OS.

Conclusion: Preoperative peripheral blood HGB is an independent risk factor for the prognosis of MIBC patients. These data suggest that HGB may be a useful prognostic marker for MIBC patients undergoing RC.

Citing Articles

Decision tree model for predicting ovarian tumor malignancy based on clinical markers and preoperative circulating blood cells.

Li Y, Zhao X, Zhou Y, Gong L, Peng E BMC Med Inform Decis Mak. 2025; 25(1):94.

PMID: 39979997 PMC: 11844102. DOI: 10.1186/s12911-025-02934-8.


Urothelial genotoxicity of environmental chemicals detected in the urine of healthy dogs and their owners.

Peterson H, Holler J, Boswell A, Trepanier L J Clin Transl Sci. 2024; 8(1):e172.

PMID: 39619067 PMC: 11604503. DOI: 10.1017/cts.2024.546.


Prognostic value of neutrophil to lymphocyte ratio for patients with bladder cancer undergoing radical cystectomy: a systematic review and meta-analysis.

Chen Z, Zhang Y, Chen T Front Oncol. 2024; 14:1463173.

PMID: 39507758 PMC: 11540557. DOI: 10.3389/fonc.2024.1463173.


Dose-Escalated Radiation Therapy as Primary Treatment for Residual Bladder Cancer After Transurethral Resection.

Chang Y, Wu Y, Tsan D, Yap W, Fan K, Chang J Adv Radiat Oncol. 2024; 9(1):101302.

PMID: 38260237 PMC: 10801638. DOI: 10.1016/j.adro.2023.101302.


Predictive models of long-term survival outcomes following radical cystectomy.

Ohtsu A, Arai S, Fujizuka Y, Miyazawa Y, Nomura M, Sekine Y Cancer Med. 2023; 12(23):21118-21128.

PMID: 37902172 PMC: 10726758. DOI: 10.1002/cam4.6670.


References
1.
Grimm T, Buchner A, Schneevoigt B, Kretschmer A, Apfelbeck M, Grabbert M . Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study. World J Urol. 2015; 34(5):703-8. DOI: 10.1007/s00345-015-1680-7. View

2.
Wilson M, van Haaren M, Harlaar J, Park H, Bonjer H, Jeekel J . Long-term prognostic value of preoperative anemia in patients with colorectal cancer: A systematic review and meta-analysis. Surg Oncol. 2017; 26(1):96-104. DOI: 10.1016/j.suronc.2017.01.005. View

3.
Peng D, Gong Y, Hao H, He Z, Li X, Zhang C . Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study. BMC Cancer. 2017; 17(1):391. PMC: 5455109. DOI: 10.1186/s12885-017-3372-8. View

4.
Black A, Zargar H, Zargar-Shoshtari K, Fairey A, Mertens L, Dinney C . The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy. Urol Oncol. 2019; 38(1):3.e17-3.e27. DOI: 10.1016/j.urolonc.2019.09.023. View

5.
Balkwill F, Mantovani A . Inflammation and cancer: back to Virchow?. Lancet. 2001; 357(9255):539-45. DOI: 10.1016/S0140-6736(00)04046-0. View